COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026
Hereditary Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hereditary Angioedema Treatment market is segmented into
The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereditary Angioedema Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis
Hereditary Angioedema Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Treatment business, the date to enter into the Hereditary Angioedema Treatment market, Hereditary Angioedema Treatment product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Hereditary Angioedema Treatment market is segmented into
- C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
- Selective Bradykinin B2 Receptor Antagonists (Firazyr)
- Kallikrein Inhibitors (Kalbitor, Takhzyro)
- Others (Conventional Drugs, Pipeline Drugs)
- Hospital Pharmacies
- Retail Pharmacies
- Others (online pharmacies, mail pharmacies)
The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereditary Angioedema Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis
Hereditary Angioedema Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Treatment business, the date to enter into the Hereditary Angioedema Treatment market, Hereditary Angioedema Treatment product introduction, recent developments, etc.
The major vendors covered:
- CSL
- Pharming Group
- Shire plc (Takeda Pharmaceutical Company Limited)
- Ionis Pharmaceuticals
- Attune Pharmaceuticals
- BioCryst Pharmaceuticals
- KalVista Pharmaceuticals
1 STUDY COVERAGE
1.1 Hereditary Angioedema Treatment Product Introduction
1.2 Market Segments
1.3 Key Hereditary Angioedema Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Type
1.4.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.4.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.4.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.4.5 Others (Conventional Drugs, Pipeline Drugs)
1.5 Market by Application
1.5.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Others (online pharmacies, mail pharmacies)
1.6 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
1.6.1.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts
2.1.1 Global Hereditary Angioedema Treatment Revenue 2015-2026
2.1.2 Global Hereditary Angioedema Treatment Sales 2015-2026
2.2 Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Hereditary Angioedema Treatment Sales by Manufacturers
3.1.1 Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020)
3.1.2 Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Hereditary Angioedema Treatment Revenue by Manufacturers
3.2.1 Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hereditary Angioedema Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Treatment Revenue in 2019
3.2.5 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hereditary Angioedema Treatment Price by Manufacturers
3.4 Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Types
3.4.1 Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereditary Angioedema Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hereditary Angioedema Treatment Market Size by Type (2015-2020)
4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2015-2020)
4.1.2 Global Hereditary Angioedema Treatment Revenue by Type (2015-2020)
4.1.3 Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Hereditary Angioedema Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hereditary Angioedema Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hereditary Angioedema Treatment Market Size by Application (2015-2020)
5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2015-2020)
5.1.2 Global Hereditary Angioedema Treatment Revenue by Application (2015-2020)
5.1.3 Hereditary Angioedema Treatment Price by Application (2015-2020)
5.2 Hereditary Angioedema Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hereditary Angioedema Treatment by Country
6.1.1 North America Hereditary Angioedema Treatment Sales by Country
6.1.2 North America Hereditary Angioedema Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Type
6.3 North America Hereditary Angioedema Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Hereditary Angioedema Treatment by Country
7.1.1 Europe Hereditary Angioedema Treatment Sales by Country
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Type
7.3 Europe Hereditary Angioedema Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Hereditary Angioedema Treatment by Region
8.1.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.1.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Type
8.3 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Hereditary Angioedema Treatment by Country
9.1.1 Latin America Hereditary Angioedema Treatment Sales by Country
9.1.2 Latin America Hereditary Angioedema Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Type
9.3 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Hereditary Angioedema Treatment by Country
10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country
10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Hereditary Angioedema Treatment Products Offered
11.1.5 CSL Recent Development
11.2 Pharming Group
11.2.1 Pharming Group Corporation Information
11.2.2 Pharming Group Description, Business Overview and Total Revenue
11.2.3 Pharming Group Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
11.2.5 Pharming Group Recent Development
11.3 Shire plc (Takeda Pharmaceutical Company Limited)
11.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
11.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description, Business Overview and Total Revenue
11.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
11.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Corporation Information
11.4.2 Ionis Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Ionis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Attune Pharmaceuticals
11.5.1 Attune Pharmaceuticals Corporation Information
11.5.2 Attune Pharmaceuticals Description, Business Overview and Total Revenue
11.5.3 Attune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.5.5 Attune Pharmaceuticals Recent Development
11.6 BioCryst Pharmaceuticals
11.6.1 BioCryst Pharmaceuticals Corporation Information
11.6.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.6.5 BioCryst Pharmaceuticals Recent Development
11.7 KalVista Pharmaceuticals
11.7.1 KalVista Pharmaceuticals Corporation Information
11.7.2 KalVista Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 KalVista Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.7.5 KalVista Pharmaceuticals Recent Development
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Hereditary Angioedema Treatment Products Offered
11.1.5 CSL Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Hereditary Angioedema Treatment Market Estimates and Projections by Region
12.1.1 Global Hereditary Angioedema Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Hereditary Angioedema Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.2.2 North America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hereditary Angioedema Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Hereditary Angioedema Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Hereditary Angioedema Treatment Product Introduction
1.2 Market Segments
1.3 Key Hereditary Angioedema Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Type
1.4.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.4.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.4.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.4.5 Others (Conventional Drugs, Pipeline Drugs)
1.5 Market by Application
1.5.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Others (online pharmacies, mail pharmacies)
1.6 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
1.6.1.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts
2.1.1 Global Hereditary Angioedema Treatment Revenue 2015-2026
2.1.2 Global Hereditary Angioedema Treatment Sales 2015-2026
2.2 Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Hereditary Angioedema Treatment Sales by Manufacturers
3.1.1 Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020)
3.1.2 Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Hereditary Angioedema Treatment Revenue by Manufacturers
3.2.1 Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hereditary Angioedema Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Treatment Revenue in 2019
3.2.5 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hereditary Angioedema Treatment Price by Manufacturers
3.4 Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Types
3.4.1 Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereditary Angioedema Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hereditary Angioedema Treatment Market Size by Type (2015-2020)
4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2015-2020)
4.1.2 Global Hereditary Angioedema Treatment Revenue by Type (2015-2020)
4.1.3 Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Hereditary Angioedema Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hereditary Angioedema Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hereditary Angioedema Treatment Market Size by Application (2015-2020)
5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2015-2020)
5.1.2 Global Hereditary Angioedema Treatment Revenue by Application (2015-2020)
5.1.3 Hereditary Angioedema Treatment Price by Application (2015-2020)
5.2 Hereditary Angioedema Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hereditary Angioedema Treatment by Country
6.1.1 North America Hereditary Angioedema Treatment Sales by Country
6.1.2 North America Hereditary Angioedema Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Type
6.3 North America Hereditary Angioedema Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Hereditary Angioedema Treatment by Country
7.1.1 Europe Hereditary Angioedema Treatment Sales by Country
7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Type
7.3 Europe Hereditary Angioedema Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Hereditary Angioedema Treatment by Region
8.1.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.1.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Type
8.3 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Hereditary Angioedema Treatment by Country
9.1.1 Latin America Hereditary Angioedema Treatment Sales by Country
9.1.2 Latin America Hereditary Angioedema Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Type
9.3 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Hereditary Angioedema Treatment by Country
10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country
10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Hereditary Angioedema Treatment Products Offered
11.1.5 CSL Recent Development
11.2 Pharming Group
11.2.1 Pharming Group Corporation Information
11.2.2 Pharming Group Description, Business Overview and Total Revenue
11.2.3 Pharming Group Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
11.2.5 Pharming Group Recent Development
11.3 Shire plc (Takeda Pharmaceutical Company Limited)
11.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
11.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description, Business Overview and Total Revenue
11.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
11.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Corporation Information
11.4.2 Ionis Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Ionis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Attune Pharmaceuticals
11.5.1 Attune Pharmaceuticals Corporation Information
11.5.2 Attune Pharmaceuticals Description, Business Overview and Total Revenue
11.5.3 Attune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.5.5 Attune Pharmaceuticals Recent Development
11.6 BioCryst Pharmaceuticals
11.6.1 BioCryst Pharmaceuticals Corporation Information
11.6.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.6.5 BioCryst Pharmaceuticals Recent Development
11.7 KalVista Pharmaceuticals
11.7.1 KalVista Pharmaceuticals Corporation Information
11.7.2 KalVista Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 KalVista Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
11.7.5 KalVista Pharmaceuticals Recent Development
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Hereditary Angioedema Treatment Products Offered
11.1.5 CSL Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Hereditary Angioedema Treatment Market Estimates and Projections by Region
12.1.1 Global Hereditary Angioedema Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Hereditary Angioedema Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.2.2 North America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hereditary Angioedema Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Hereditary Angioedema Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Hereditary Angioedema Treatment Market Segments
Table 2. Ranking of Global Top Hereditary Angioedema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hereditary Angioedema Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Table 5. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Table 6. Major Manufacturers of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Table 7. Major Manufacturers of Others (Conventional Drugs, Pipeline Drugs)
Table 8. COVID-19 Impact Global Market: (Four Hereditary Angioedema Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Hereditary Angioedema Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
Table 13. Global Hereditary Angioedema Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Hereditary Angioedema Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Hereditary Angioedema Treatment Sales by Regions 2015-2020 (K Units)
Table 16. Global Hereditary Angioedema Treatment Sales Market Share by Regions (2015-2020)
Table 17. Global Hereditary Angioedema Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturers (2015-2020)
Table 20. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2019)
Table 22. Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Hereditary Angioedema Treatment Price (2015-2020) (USD/Unit)
Table 25. Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Hereditary Angioedema Treatment Product Type
Table 27. Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 30. Global Hereditary Angioedema Treatment Sales Share by Type (2015-2020)
Table 31. Global Hereditary Angioedema Treatment Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Hereditary Angioedema Treatment Revenue Share by Type (2015-2020)
Table 33. Hereditary Angioedema Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 35. Global Hereditary Angioedema Treatment Sales Share by Application (2015-2020)
Table 36. North America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 37. North America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 38. North America Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 40. North America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 41. North America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 42. North America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 43. North America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 44. Europe Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 45. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 46. Europe Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 48. Europe Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 49. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 50. Europe Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 51. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 60. Latin America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 61. Latin America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 64. Latin America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 65. Latin America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 66. Latin America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 67. Latin America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 76. CSL Corporation Information
Table 77. CSL Description and Major Businesses
Table 78. CSL Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. CSL Product
Table 80. CSL Recent Development
Table 81. Pharming Group Corporation Information
Table 82. Pharming Group Description and Major Businesses
Table 83. Pharming Group Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Pharming Group Product
Table 85. Pharming Group Recent Development
Table 86. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
Table 87. Shire plc (Takeda Pharmaceutical Company Limited) Description and Major Businesses
Table 88. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Shire plc (Takeda Pharmaceutical Company Limited) Product
Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 91. Ionis Pharmaceuticals Corporation Information
Table 92. Ionis Pharmaceuticals Description and Major Businesses
Table 93. Ionis Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Ionis Pharmaceuticals Product
Table 95. Ionis Pharmaceuticals Recent Development
Table 96. Attune Pharmaceuticals Corporation Information
Table 97. Attune Pharmaceuticals Description and Major Businesses
Table 98. Attune Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Attune Pharmaceuticals Product
Table 100. Attune Pharmaceuticals Recent Development
Table 101. BioCryst Pharmaceuticals Corporation Information
Table 102. BioCryst Pharmaceuticals Description and Major Businesses
Table 103. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. BioCryst Pharmaceuticals Product
Table 105. BioCryst Pharmaceuticals Recent Development
Table 106. KalVista Pharmaceuticals Corporation Information
Table 107. KalVista Pharmaceuticals Description and Major Businesses
Table 108. KalVista Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. KalVista Pharmaceuticals Product
Table 110. KalVista Pharmaceuticals Recent Development
Table 111. Global Hereditary Angioedema Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Hereditary Angioedema Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Hereditary Angioedema Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Hereditary Angioedema Treatment Players
Table 129. Hereditary Angioedema Treatment Customers List
Table 130. Hereditary Angioedema Treatment Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Hereditary Angioedema Treatment Market Segments
Table 2. Ranking of Global Top Hereditary Angioedema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hereditary Angioedema Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Table 5. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Table 6. Major Manufacturers of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Table 7. Major Manufacturers of Others (Conventional Drugs, Pipeline Drugs)
Table 8. COVID-19 Impact Global Market: (Four Hereditary Angioedema Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Hereditary Angioedema Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
Table 13. Global Hereditary Angioedema Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Hereditary Angioedema Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Hereditary Angioedema Treatment Sales by Regions 2015-2020 (K Units)
Table 16. Global Hereditary Angioedema Treatment Sales Market Share by Regions (2015-2020)
Table 17. Global Hereditary Angioedema Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturers (2015-2020)
Table 20. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2019)
Table 22. Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Hereditary Angioedema Treatment Price (2015-2020) (USD/Unit)
Table 25. Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Hereditary Angioedema Treatment Product Type
Table 27. Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 30. Global Hereditary Angioedema Treatment Sales Share by Type (2015-2020)
Table 31. Global Hereditary Angioedema Treatment Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Hereditary Angioedema Treatment Revenue Share by Type (2015-2020)
Table 33. Hereditary Angioedema Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 35. Global Hereditary Angioedema Treatment Sales Share by Application (2015-2020)
Table 36. North America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 37. North America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 38. North America Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 40. North America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 41. North America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 42. North America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 43. North America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 44. Europe Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 45. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 46. Europe Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 48. Europe Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 49. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 50. Europe Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 51. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 60. Latin America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 61. Latin America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 64. Latin America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 65. Latin America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 66. Latin America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 67. Latin America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 76. CSL Corporation Information
Table 77. CSL Description and Major Businesses
Table 78. CSL Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. CSL Product
Table 80. CSL Recent Development
Table 81. Pharming Group Corporation Information
Table 82. Pharming Group Description and Major Businesses
Table 83. Pharming Group Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Pharming Group Product
Table 85. Pharming Group Recent Development
Table 86. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
Table 87. Shire plc (Takeda Pharmaceutical Company Limited) Description and Major Businesses
Table 88. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Shire plc (Takeda Pharmaceutical Company Limited) Product
Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 91. Ionis Pharmaceuticals Corporation Information
Table 92. Ionis Pharmaceuticals Description and Major Businesses
Table 93. Ionis Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Ionis Pharmaceuticals Product
Table 95. Ionis Pharmaceuticals Recent Development
Table 96. Attune Pharmaceuticals Corporation Information
Table 97. Attune Pharmaceuticals Description and Major Businesses
Table 98. Attune Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Attune Pharmaceuticals Product
Table 100. Attune Pharmaceuticals Recent Development
Table 101. BioCryst Pharmaceuticals Corporation Information
Table 102. BioCryst Pharmaceuticals Description and Major Businesses
Table 103. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. BioCryst Pharmaceuticals Product
Table 105. BioCryst Pharmaceuticals Recent Development
Table 106. KalVista Pharmaceuticals Corporation Information
Table 107. KalVista Pharmaceuticals Description and Major Businesses
Table 108. KalVista Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. KalVista Pharmaceuticals Product
Table 110. KalVista Pharmaceuticals Recent Development
Table 111. Global Hereditary Angioedema Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Hereditary Angioedema Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Hereditary Angioedema Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Hereditary Angioedema Treatment Players
Table 129. Hereditary Angioedema Treatment Customers List
Table 130. Hereditary Angioedema Treatment Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Picture
Figure 4. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Picture
Figure 5. Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Picture
Figure 6. Others (Conventional Drugs, Pipeline Drugs) Product Picture
Figure 7. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Others (online pharmacies, mail pharmacies)
Figure 11. Hereditary Angioedema Treatment Report Years Considered
Figure 12. Global Hereditary Angioedema Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Hereditary Angioedema Treatment Sales 2015-2026 (K Units)
Figure 14. Global Hereditary Angioedema Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Hereditary Angioedema Treatment Sales Market Share by Region in 2019
Figure 17. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Hereditary Angioedema Treatment Revenue Market Share by Region in 2019
Figure 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Hereditary Angioedema Treatment Revenue in 2019
Figure 21. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 24. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2019
Figure 26. Global Hereditary Angioedema Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 29. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Hereditary Angioedema Treatment Revenue Market Share by Application in 2019
Figure 31. North America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 34. North America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 40. North America Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 41. Europe Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 44. Europe Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 56. Europe Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region in 2019
Figure 61. China Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 85. Latin America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 96. Latin America Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 109. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pharming Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shire plc (Takeda Pharmaceutical Company Limited) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Attune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. KalVista Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Picture
Figure 4. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Picture
Figure 5. Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Picture
Figure 6. Others (Conventional Drugs, Pipeline Drugs) Product Picture
Figure 7. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Others (online pharmacies, mail pharmacies)
Figure 11. Hereditary Angioedema Treatment Report Years Considered
Figure 12. Global Hereditary Angioedema Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Hereditary Angioedema Treatment Sales 2015-2026 (K Units)
Figure 14. Global Hereditary Angioedema Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Hereditary Angioedema Treatment Sales Market Share by Region in 2019
Figure 17. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Hereditary Angioedema Treatment Revenue Market Share by Region in 2019
Figure 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Hereditary Angioedema Treatment Revenue in 2019
Figure 21. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 24. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2019
Figure 26. Global Hereditary Angioedema Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 29. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Hereditary Angioedema Treatment Revenue Market Share by Application in 2019
Figure 31. North America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 34. North America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 40. North America Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 41. Europe Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 44. Europe Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 56. Europe Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region in 2019
Figure 61. China Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 85. Latin America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 96. Latin America Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Hereditary Angioedema Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Hereditary Angioedema Treatment Market Share by Application in 2019
Figure 109. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pharming Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shire plc (Takeda Pharmaceutical Company Limited) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Attune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. KalVista Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
